Table 2 CXCL16 and CXCR6 expression as predictors of disease-specific survival in 335 NSCLC patients
Characteristics | Patients, N (%) | Median survival (months) | 5-year survival (%) | P |
|---|---|---|---|---|
CXCL16 | ||||
 Cancer cells |  |  |  | .080 |
  High | 48 (14) | NR | 67 |  |
  Low | 227 (68) | 98 | 56 |  |
  Missing | 60 (18) |  |  |  |
 Stromal cells |  |  |  | .016 |
  High | 258 (77) | 189 | 62 |  |
  Low | 43 (13) | 57 | 48 |  |
  Missing | 34 (10) |  |  |  |
CXCR6 | ||||
 Cancer cells |  |  |  | .093 |
  High | 41 (12) | 190 | 73 |  |
  Low | 245 (73) | 122 | 55 |  |
  Missing | 49 (15) |  |  |  |
CXCL16 | ||||
 Cancer cells + stromal cells combined |  |  |  | .016 |
  High/High | 43 (13) | NR | 71 |  |
  High/Low | 182 (54) | 190 | 58 |  |
  Low/Low | 41 (12) | 47 | 48 |  |
  Missing | 69 (21) |  |  |  |